Share on StockTwits

Perrigo Company PLC (NASDAQ:PRGO) EVP Sharon Kochan sold 1,116 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $150.00, for a total value of $167,400.00. Following the completion of the sale, the executive vice president now directly owns 5,400 shares of the company’s stock, valued at approximately $810,000. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Perrigo Company PLC (NASDAQ:PRGO) traded down 2.58% on Thursday, hitting $146.07. The stock had a trading volume of 885,635 shares. Perrigo Company PLC has a 1-year low of $122.12 and a 1-year high of $168.39. The stock has a 50-day moving average of $149. and a 200-day moving average of $148.7. The company has a market cap of $19.547 billion and a price-to-earnings ratio of 84.71.

Perrigo Company PLC (NASDAQ:PRGO) last posted its quarterly earnings results on Thursday, August 14th. The company reported $1.74 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.55 by $0.19. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. Analysts expect that Perrigo Company PLC will post $7.38 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 16th. Investors of record on Friday, August 29th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date of this dividend is Wednesday, August 27th.

PRGO has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Monday, August 18th. They now have a $156.00 price target on the stock. Separately, analysts at B. Riley upgraded shares of Perrigo Company PLC from a “neutral” rating to a “buy” rating in a research note on Friday, August 15th. They now have a $180.00 price target on the stock, up previously from $157.00. Finally, analysts at Jefferies Group raised their price target on shares of Perrigo Company PLC from $160.00 to $176.00 in a research note on Friday, August 15th. They now have a “buy” rating on the stock. Three equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $166.92.

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.